Kimia Biosciences Limited (BOM:530313)

Kimia Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	7.11	2.06	1.48	1.78	2.05	5.87
Trading Asset Securities	-	-	-	0.63	0.6	0.58
Cash & Short-Term Investments	7.11	2.06	1.48	2.41	2.65	6.45
Cash Growth	-	39.63%	-38.73%	-9.20%	-58.87%	-0.62%
Accounts Receivable	281.83	367.51	275.54	305.9	302.01	417.66
Other Receivables	-	7.5	5.36	5.78	36.69	16.37
Receivables	281.83	375.01	280.9	311.67	338.7	434.03
Inventory	346.52	345.83	308.04	482.34	370.18	236.87
Prepaid Expenses	-	2.15	1.32	1.42	3.15	2.62
Other Current Assets	19.55	27.87	22.35	29.63	16.01	38.45
Total Current Assets	655.01	752.92	614.08	827.47	730.7	718.41
Property, Plant & Equipment	298.88	309.02	323.8	341.53	350.82	340.43
Other Intangible Assets	39.46	0.22	0.41	0.85	1.45	0.95
Long-Term Deferred Tax Assets	17.4	17.63	57.84	39.69	9.08	-
Long-Term Deferred Charges	-	23.57	-	-	-	-
Other Long-Term Assets	4.16	8.77	3.54	3.64	2.86	6.9
Total Assets	1,015	1,112	999.67	1,213	1,095	1,067
Accounts Payable	478.69	504.89	399.88	465.86	402.06	307.86
Accrued Expenses	-	51.61	57.55	50.93	29.71	25.29
Short-Term Debt	-	196.38	197.91	198.32	148.1	131.27
Current Portion of Long-Term Debt	194.1	25.58	22.01	22.52	13.6	34.57
Current Portion of Leases	2.01	1.86	1.21	-	-	-
Current Unearned Revenue	-	37.93	15.03	22.97	16.99	6.14
Other Current Liabilities	42.21	0	0.79	3.38	7.56	4.36
Total Current Liabilities	717	818.25	694.38	763.98	618.02	509.48
Long-Term Debt	163	167	272.17	361.63	293.33	328.3
Long-Term Leases	1.71	2.76	1.85	-	-	-
Long-Term Unearned Revenue	-	8.48	13.48	18.48	23.47	28.47
Pension & Post-Retirement Benefits	-	14.15	12.68	12.53	11.21	11.69
Long-Term Deferred Tax Liabilities	-	-	-	-	-	4.38
Other Long-Term Liabilities	17.35	1.81	1.81	1.92	-	-
Total Liabilities	899.07	1,012	996.36	1,159	946.03	882.33
Common Stock	47.31	47.31	47.31	47.31	47.31	47.31
Additional Paid-In Capital	-	60.85	60.85	60.85	60.85	60.85
Retained Earnings	-	-8.5	-104.86	-53.54	40.72	76.2
Comprehensive Income & Other	68.54	-	-	-	-	-
Total Common Equity	115.85	99.66	3.31	54.63	148.88	184.36
Shareholders' Equity	115.85	99.66	3.31	54.63	148.88	184.36
Total Liabilities & Equity	1,015	1,112	999.67	1,213	1,095	1,067
Total Debt	360.82	393.58	495.14	582.47	455.03	494.14
Net Cash (Debt)	-353.72	-391.52	-493.67	-580.06	-452.38	-487.69
Net Cash Per Share	-7.48	-8.28	-10.43	-12.26	-9.56	-10.31
Filing Date Shares Outstanding	48.34	47.31	47.31	47.31	47.31	47.31
Total Common Shares Outstanding	48.34	47.31	47.31	47.31	47.31	47.31
Working Capital	-61.99	-65.33	-80.3	63.49	112.68	208.93
Book Value Per Share	2.40	2.11	0.07	1.15	3.15	3.90
Tangible Book Value	76.39	99.44	2.9	53.78	147.44	183.41
Tangible Book Value Per Share	1.58	2.10	0.06	1.14	3.12	3.88
Land	-	4.75	4.75	4.75	4.75	4.75
Buildings	-	61.17	61.17	60	60	51.6
Machinery	-	423.4	401.66	390.95	373.58	285.53
Construction In Progress	-	0.03	5.76	6.06	-	57.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.